Bharat Immunologicals Financial Statements Trends

BIBCL -- India Stock  

INR 8.58  0.03  0.35%

This module enables investors to look at Bharat Immunologicals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as , but also many exotic indicators such as . This module is a perfect complement to use when analyzing Bharat Immunologicals Valuation or Volatility. It can also complement various Bharat Immunologicals Technical models. Check also Trending Equities.

Bharat Immunologicals Operating Margin Analysis

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Operating Margin 
 = 
Operating Income 
Revenue 
X
100 
More About Operating Margin | All Equity Analysis
Bharat Immunologicals Operating Margin  =
(11.00)%
Bharat Immunologicals ValuationFundamentalsBuy or Sell

About Operating Margin

A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.Compare to competition
Based on recorded statements Bharat Immunologicals Biologicals Corp Ltd has Operating Margin of -11.0%. This is much lower than that of the Healthcare sector, and significantly lower than that of Biotechnology industry, The Operating Margin for all stocks is notably higher than the company.

Bharat Immunologicals Fundamental Drivers Relationships

Bharat Immunologicals Biologicals Corp Ltd is number one stock in current ratio category among related companies. It is number one stock in operating margin category among related companies .
Search macroaxis.com